A folate antagonist, methotrexate (MTX), inhibits dihydrofolate reductase that reduces dihydrofolate to tetrahydrofolate. MTX therefore limits the availability of one-carbon fragments necessary for the synthesis of purines and interferes with the conversion of deoxyuridylate to thymidylate in the synthesis of DNA and cell proliferation \[[@r9], [@r14], [@r26]\]. MTX is known to induce apoptosis, and the mechanism of MTX-induced apoptosis is considered to be associated with the up-regulation of p53 and p21 proteins \[[@r22], [@r36]\], repression of the induction of c-Jun N-terminal kinase (JNK) activity, expression of the CD95 receptor/ligand system \[[@r27]\] and reactive oxygen species \[[@r11], [@r36]\].

MTX has been used in the treatment of malignancy, autoimmune and inflammatory diseases and gestational trophoblast disease \[[@r3], [@r4], [@r9]\]. MTX is also used as an abortifacient, both for the voluntary termination of pregnancy and for the medical management of ectopic pregnancy \[[@r24]\]. Medical treatment protocols for MTX were established in the 1980s and have become a widely accepted primary treatment for unruptured ectopic pregnancy \[[@r25], [@r32], [@r33]\]. In humans, MTX embryopathy results from failed pregnancy termination with MTX or when mothers who are taking MTX for medical reasons become pregnant inadvertently \[[@r1], [@r2], [@r14], [@r35]\]. The anomalies of MTX embryopathy include nervous system anomalies, growth deficiency, craniofacial deformities and skeletal defects \[[@r14], [@r26]\]. As the central nervous system anomalies in MTX embryopathy, alobar/semilobar holoprosencephaly \[[@r2], [@r35]\], cerebellar hypoplasia \[[@r35]\], agenesis of the corpus callosum \[[@r35]\] and microcephaly \[[@r1], [@r8]\] have been reported. However, there are few reports to examine the brain anomalies in MTX embryopathy histopathologically, and their detailed histopathogical findings or their detailed pathogenesis remain unclear. In experimental animals, prenatal MTX exposure reportedly induced anomalies of the brain in chicken \[[@r44]\] and rabbits \[[@r16]\]. In rabbit, MTX administration on gestation days (GD) 10--12 or GD 12 caused hydrocephalus \[[@r5], [@r16]\]. However, there are few reports to date describing damage to the fetal brain following MTX administration to dams, and detailed effects of prenatal MTX treatment on fetal brain have been not completely elucidated even in experimental animals. Therefore, in the present study, we examined histopathologically the time-dependent changes of fetal brain following MTX administration to their dams on GD 13 to clarify pathogenesis of MTX-induced brain anomalies in fetuses.

MATERIALS AND METHODS {#s1}
=====================

*Animals*: All experiments were performed using female Wistar Imamichi rats, 9--10 weeks of age, 218.45 ± 2.09 g (mean ± SE) in weight, and obtained from the Institute of Animal Reproduction (Kasumigaura, Japan). The animals were reared in a room with the temperature controlled at 22 ± 2°C, humidity at 50 ± 5%, with ventilation 11 times per hr, lighting at 12:12-hr light/dark cycle (light cycle, 7:00--19:00) and given standard chow (CE-2; Nihon Clea, Tokyo, Japan). The present experiments were performed following the provisions approved by the Animal Research Committee of Tottori University.

*Experimental design*: A total of 40 animals were divided into 2 groups as follows: (1) saline-treated control rats (n=20), (2) MTX-treated rats (n=20). MTX (Pfizer Japan Inc., Tokyo, Japan) was dissolved in saline. Day 0 of gestation (GD 0) was designated as the day when the presence of a vaginal plug was identified. The rats received intraperitoneal injections (i.p.) with MTX (30 mg/kg body weight) or saline (the control) on GD 13. The specific timing of MTX administration was selected, because the injection of DNA damaging chemicals, such as ethylnitrosourea (ENU) \[[@r19],[@r20],[@r21]\], 6-mercaptopurine (6-MP) \[[@r17]\], busulfan \[[@r30]\], T-2 toxin \[[@r34]\], 1-β-D-arabinofuranosylcytosine (Ara-C) \[[@r43]\], 5-azacytidine (5AzC) \[[@r39], [@r40]\] and 5-Fluorouracil (5-Fu) \[[@r42]\], on GD13 induced apoptosis in neuroepithelial cells of telencephalon in rat fetal brain. The dose level in the present study was decided, because this dose was equivalent to 10% of the LD50 in intraperitoneal injection in rats or 15−30% of dosage used in high-dose cancer therapy in human \[[@r12], [@r15], [@r23]\]. Fetus samples were collected under pentobarbital anesthesia (100 mg/kg, i.p.) 6, 12, 24, 36 and 48 hr, respectively, after MTX administration. They were removed from the uterus and weighed, and their body lengths were measured.

*Histopathological examination*: For histopathological examination, all fetuses were fixed in 10% neutral buffered formalin and then embedded in paraffin. The tissues of telencephalon, diencephalon, mesencephalon and metencephalon in 12 fetal brain samples per group consisted of 3 fetuses ramdomly selected per dam in each group were sectioned at 2 *µ*m thickness, stained with hematoxylin and eosin and examined with light microscopy. The number of pyknotic cells or mitotic cells was counted from over 1,000 neuroepithelial cells in the telencephalon, diencephalon, mesencephalon and metencephalon for each fetus by light microscopy, and the pyknotic index and mitotic index were calculated as the percentage of pyknotic cells or mitotic cells from out of the total number of neuroepithelial cells counted.

*TUNEL method*: DNA-fragmented neuroepithelial cells in telencephalon were detected by terminal deoxynucleotidyl-transferase (TdT)-mediated deoxyuridine triphosphate-digoxigenin (dUTP) nick-end labeling (TUNEL), which was performed using an *in situ* apoptosis detection kit (Trevigen, Inc., Gaithersburg, MD, U.S.A.). The number of TUNEL-positive cells was obtained from over 1,000 neuroepithelial cells in the telencephalon for each fetus by light microscopy, and the TUNEL-index was calculated as the percentage of TUNEL-positive cells out of the total number of neuroepithelial cells counted.

*Immunohistochemical examinations of rat fetuses*: Immunohistochemical staining was performed by a labeled-polymer method using Histofine Simple Stain MAX-PO (R) (Nichirei, Tokyo, Japan). To retrieve the antigen, tissue sections for the detection of cleaved caspase-3 antigen were immersed in citrate buffer, pH 6.0 (Dako, Glostrup, Denmark) and autoclaved for 15 min at 121°C; and tissue sections for the detection of phospho-histone H3 antigen were immersed in citrate buffer, pH 6.0 (Dako) and microwaved for 15 min. Endogenous peroxidase activity was quenched by immersing the sections in 3% hydrogen peroxide in methanol for 15 min. The sections were incubated with the cleaved caspase-3 rabbit polyclonal antibody (1:300 dilution; Cell Signaling Technology, Inc., Danvers, MA, U.S.A.) at 4°C overnight; and the sections were incubated with the phospho-histone H3 rabbit monoclonal antibody (1:1,500 dilution; Abcam, Tokyo, Japan) for 30 min at room temperature. Then, these sections were treated with Histofine Simple Stain MAX-PO (R) (Nichirei) for 30 min at room temperature. They were exposed to a 3,3′-diaminobenzidine solution containing hydrogen peroxide (Nichirei) to facilitate a peroxidase color reaction and then counterstained with Mayer's hematoxylin. The number of cleaved caspase-3- or phospho-histone H3-positive cells was counted from over 1,000 neuroepithelial cells in the telencephalon for each fetus by light microscopy, and the cleaved caspase-3- or phospho-histone H3-index was calculated as the percentage of cleaved caspase-3- or phospho-histone H3-positive cells out of the total number of neuroepithelial cells counted.

*Statistical analysis*: Means ± standard error (SE) of the individual litter value was calculated. The data were analyzed with an *F*-test. When variances were homogeneous, the Student's *t*-test was performed. Welch's *t*-test was employed when variances were not homogeneous (*P*\<0.05). *P*\<0.05, *P*\<0.01 or *P*\<0.001 was considered to be statistically significant.

RESULTS {#s2}
=======

*Effects of MTX on rat fetuses*: Six, 12 and 24 hr after MTX treatment, there were no significant differences in the number of living fetuses per litter and the fetal mortality rates between the control group and MTX-treated group ([Table 1](#tbl_001){ref-type="table"}Table 1.Effects of methotrexate on rat fetusesTreatmentNo. of damsTotal No. of live fetusesLiving fetuses per litterDead fetus ratio (%)6 hrControl45814.59 ± 0.509.03 ± 3.03MTX45714.25 ± 0.633.14 ±1.8212 hrControl45614.00 ± 0.417.93 ± 3.00MTX46315.75 ± 2.5015.92 ± 10.6724 hrControl45814.50 ± 1.447.63 ± 4.81MTX45714.25 ± 0.956.48 ± 4.4436 hrControl46215.50 ± 1.193.58 ± 3.58MTX44411.00 ± 0.41\*30.30 ± 5.41\*\*48 hrControl45614.00 ± 1.004.73 ± 3.15MTX410.25 ± 0.25†††98.53 ± 1.48\*\*\*Values are expressed as means ± SE. \*, \*\*, \*\*\*: Significantly different from control at *P*\<0.05, *P*\<0.01, *P*\<0.001, respectively (Student's *t*-test). †††: Significantly different from control at *P*\<0.001 (Welch's *t*-test).). The number of living fetuses significantly declined, and fetal mortality rates significantly increased at 36 hr in the MTX-treated group, compared to those of the control group ([Table 1](#tbl_001){ref-type="table"}). Almost all fetuses died by 48 hr after MTX treatment ([Table 1](#tbl_001){ref-type="table"}).

*Histopathological findings of rat fetal brain*: In the control group, pyknotic changes in neuroepithelial cells were rarely observed in any layers of the telencephalic wall throughout the experimental period ([Figs. 1](#fig_001){ref-type="fig"} and[2](#fig_002){ref-type="fig"}Fig. 1.Histopathological findings of telencephalic wall of rat fetal brain in the control group 6 hr after treatment (A) and the MTX-treated group at 6 (B), 12 (C), 24 (D) and 36 hr (E), respectively. (A) Arrowheads indicate mitotic cells. (B) Arrows indicate pyknotic cells. Bar=30 *µ*m.Fig. 2.Changes in the pyknotic index (%) in telencephalic wall of rat fetal brain. Values are expressed as means ± SE. †, †††: Significantly different from control at *P*\<0.05, *P*\<0.001, respectively (Welch's *t*-test).).

Six hr after treatment in the MTX-treated group, pyknotic neuroepithelial cells appeared in the telencephalic wall and scattered throughout that wall ([Fig. 1B](#fig_001){ref-type="fig"}). Then, 12--36 hr after MTX treatment, pyknotic neuroepithelial cells drastically increased and were diffusely distributed throughout the telencephalic wall ([Figs. 1](#fig_001){ref-type="fig"}C--[1](#fig_001){ref-type="fig"}E and[2](#fig_002){ref-type="fig"}). At 36 hr, neuroepithelial cells were eliminated and showed low cell density in the telencephalon of MTX-treated group ([Fig. 1E](#fig_001){ref-type="fig"}). Although mitotic neuroepithelial cells were located along the ventricular layer of the telencephalic wall in the control group, they were rarely observed in the same region at 6--36 hr in the MTX-treated group ([Fig. 1B--1E](#fig_001){ref-type="fig"}).

In the telencephalon of the control group, TUNEL-positive neuroepithelial cells were rarely observed in any layers of the telencephalic wall throughout the experimental period ([Figs. 3](#fig_003){ref-type="fig"}A and[4](#fig_004){ref-type="fig"}Fig. 3.TUNEL-positive cells in telencephalic wall of rat fetal brain in the control group 6 hr after treatment (A) and the MTX-treated group at 6 (B), 12 (C), 24 (D) and 36 hr (E). Bar=30 *µ*m.). Most of the pyknotic neuroepithelial cells were positively stained by the TUNEL method at 12, 24 and 36 hr in the MTX-treated group ([Fig. 3C--3E](#fig_003){ref-type="fig"}), while there were few pyknotic neuroepithelial cells positively stained by the TUNEL method at 6 hr ([Fig. 3B](#fig_003){ref-type="fig"}). In the MTX-treated group, the index of TUNEL-positive neuroepithelial cells in the telencephalic wall significantly increased at 12 and 24 hr and peaked at 36 hr ([Fig. 4](#fig_004){ref-type="fig"}Fig. 4.Changes in the TUNEL index (%) in telencephalic wall of rat fetal brain. Values are expressed as means ± SE. ††, †††: Significantly different from control at *P*\<0.01, *P*\<0.001, respectively (Welch's *t*-test).).

Cleaved caspase-3-positive neuroepithelial cells were rarely observed in the telencephalon of control group throughout the experimental period ([Figs. 5](#fig_005){ref-type="fig"}A and[6](#fig_006){ref-type="fig"}Fig. 5.Immunohistochemical expression of cleaved caspase-3 in telencephalic wall of rat fetal brain in the control group 6 hr after treatment (A) and the MTX-treated group at 6 (B), 12 (C), 24 (D) and 36 hr (E). Bar=30 *µ*m), although in the MTX-treated group, almost all pyknotic neuroepithelial cells were immunohistochemically positive for cleaved caspase-3 throughout the experimental period ([Fig. 5B--5E](#fig_005){ref-type="fig"}). In the MTX-treated group, the index of cleaved caspase-3-positive neuroepithelial cells in the telencephalon significantly increased at 6, 12 and 24 hr and peaked at 36 hr ([Fig. 6](#fig_006){ref-type="fig"}Fig. 6.Cleaved caspase-3 index. Values are expressed as means ± SE. †, †††: Significantly different from control at *P*\<0.05, *P*\<0.001, respectively (Welch's *t*-test).).

Phospho-histone H3-positive neuroepithelial cells were located along the ventricular layer of the telencephalic wall in the control group, while there were fewer phospho-histone H3-positive cells at 6--36 hr in the same region of the MTX-treated group than in the control group ([Fig. 7A--7E](#fig_007){ref-type="fig"}Fig. 7.Immunohistochemical expression of phospho-histone H3 in telencephalic wall of rat fetal brain in the control group 6 hr after treatment (A) and the MTX-treated group at 6 (B), 12 (C), 24 (D) and 36 hr (E), respectively. Bar=30 *µ*m.). The index of phospho-histone H3-positive neuroepithelial cells in telencephalon decreased significantly at 6 hr compared with the control group and maintained that low level throughout the experimental period ([Fig. 8](#fig_008){ref-type="fig"}Fig. 8.Phospho-histone H3 index. Values are expressed as means ± SE. \*\*\*: Significantly different from control at *P*\<0.001 (Student's *t*-test). ††: Significantly different from control at *P*\<0.01 (Welch's *t*-test).).

In the MTX-treated group, pyknotic indices of telencephalon and diencephalon significantly increased at 12--36 hr, and those of the mesencephalon significantly increased at 24 and 36 hr, compared to the control group ([Table 2](#tbl_002){ref-type="table"}Table 2.Pyknotic index (%) in rat fetal brain treated by MTX6 hr12 hr24 hr36 hrTelencephalonControl0.03 ± 0.030.05 ± 0.050.10 ± 0.070.28 ± 0.14MTX2.68 ± 0.8519.98 ± 2.45^††^34.82 ± 2.17^†††^43.33 ± 3.07^†††^DiencephalonControl0.61 ± 0.280.79 ± 0.300.66 ± 0.360.81 ± 0.30MTX1.61 ± 0.3814.31 ± 1.53^††^20.88 ± 2.44^††^20.65 ± 1.67^††^MesencephalonControl0.39 ± 0.040.41 ± 0.110.29 ± 0.110.47 ± 0.12MTX0.37 ± 0.187.78 ± 2.8826.90 ± 5.45^†^36.56 ± 3.99^††^MetencephalonControl0.00 ± 0.000.00 ± 0.000.00 ± 0.000.07 ± 0.05MTX0.04 ± 0.020.00 ± 0.002.34 ± 1.523.88 ± 0.72^†^Values are expressed as means ± SE (%). †, ††, †††: Significantly different from control at *P*\<0.05, *P*\<0.01, *P*\<0.001 respectively (Welch's *t*-test).). The pyknotic index of metencephalon significantly increased at 36 hr compared to control group, and it showed a clearly lower value, compared to those of the telencephalon, diencephalon and mesencephalon ([Table 2](#tbl_002){ref-type="table"}). In the MTX-treated group, there were fewer pyknotic neuroepithelial cells in the metencephalon than in the telencephalon, diencephalon and mesencephalon. In the MTX-treated group, while mitotic indices of telencephalon, diencephalon and mesencephalon decreased significantly at 6--36 hr, that of metencephalon decreased significantly at 6 and 12 hr compared to the control group ([Table 3](#tbl_003){ref-type="table"}Table 3.Mitotic index (%) in rat fetal brain treated by MTX6 hr12 hr24 hr36 hrTelencephalonControl4.56 ± 0.204.48 ± 0.254.82 ± 0.244.50 ± 0.09MTX0.53 ± 0.05^†††^0.24 ± 0.03^†††^0.16 ± 0.08^\*\*\*^0.22 ± 0.13^\*\*\*^DiencephalonControl3.01 ± 0.283.30 ± 0.332.56 ± 0.363.66 ± 0.28MTX0.37 ± 0.08^\*\*\*^0.57 ± 0.09^\*\*\*^0.37 ± 0.09^††^0.40 ± 0.20^\*\*\*^MesencephalonControl3.64 ± 0.433.76 ± 0.353.51 ± 0.444.53 ± 0.34MTX0.64 ± 0.17^\*\*\*^0.96 ± 0.10^\*\*\*^0.22 ± 0.07^††^1.13 ± 0.27^\*\*\*^MetencephalonControl3.12 ± 0.643.25 ± 0.251.37 ± 0.251.25 ± 0.10MTX0.67 ± 0.08^†^1.40 ± 0.35^\*\*^1.53 ± 0.471.60 ± 0.26Values are expressed as means ± SE (%). \*\*, \*\*\*: Significantly different from control at *P*\<0.01, *P*\<0.001 respectively (Student's *t*-test). †, ††, †††: Significantly different from control at *P*\<0.05, *P*\<0.01, *P*\<0.001 respectively (Welch's *t*-test).).

DISCUSSION {#s3}
==========

It has been reported that microcephaly can occur as one of the central nervous system anomalies of MTX embryopathy in humans \[[@r1], [@r8]\]. The pathogenesis of microcephaly was closely associated with excessive neuronal death \[[@r7], [@r31], [@r38]\]. The cause of MTX-induced microcephaly may be also associated with excessive neuronal death. In the present study, the majority of pyknotic neuroepithelial cells in the telencephalic wall were positive for TUNEL staining and cleaved caspase-3. Cleavage of caspase-3 is known to be involved in cell apoptosis and is recognized as an apoptosis marker \[[@r10]\]. These results indicate that pyknotic changes induced by MTX in the present study are caused by apoptosis. In the present study, pyknotic neuroepithelial cells in the telencephalon at 6 hr were positive for cleaved caspase-3, but negative for TUNEL staining. This result may reflect that the cleavage of caspase-3 precedes DNA fragmentation in the process of the neuroepithelial cell apoptosis induced by MTX.

The previous studies showed that DNA-damaging chemical administration at GD 12 or 13 induces apoptosis in neuroepithelial cells of the telencephalic wall of fetal brain \[[@r19],[@r20],[@r21], [@r28], [@r30], [@r39],[@r40],[@r41],[@r42]\]. These apoptotic neuroepithelial cells are mainly observed in the dorsal layer after treatment with ENU \[[@r6], [@r19],[@r20],[@r21]\] in the medial to dorsal layer after treatment with hydroxyurea \[[@r41]\], 5-Fu \[[@r6], [@r42]\], busulfan \[[@r30]\] and etoposide \[[@r28]\] and in the ventral to medial layers after treatment with 5AzC \[[@r6], [@r39], [@r40]\]. In the present study, apoptotic neuroepithelial cells localized throughout all layers of the telencephalic wall, but their distribution was different from those of apoptotic neuroepithelial cells induced by the above-mentioned other DNA-damaging chemicals ([Table 4](#tbl_004){ref-type="table"}Table 4.Location of apoptotic cells in the ventricular zone of telencephalon after treatment with DNA-damaging chemicalsLocation of apoptotic cells in the ventricular zone of telencephalonEthylnitrosoureaDorsal layerHydroxyurea, Busulfan, Etoposide, 5-FluorouracilMedial to dorsal layers5-AzacytidineVentral to medial layersMethotrexateAll layers). It is known that in the ventricular zone of fetal brain, the positions of the nuclei of neuroepithelial cells are correlated with their cell cycle phase \[[@r6]\]. S-phase nuclei are located in the dorsal layer of the ventricular zone \[[@r6]\]. They migrate inward during the G2 phase, and mitosis occurs at the ventricular surface \[[@r6]\]. Then, they migrate outward during the G1 phase and enter the S phase again \[[@r6]\]. In brief, the nuclei during the G1 or G2 phase are in the middle layer of the ventricular zone. The distribution of apoptotic neuroepithelial cells throughout all layers of the telencephalic wall in the present study may reflect that MTX induces apoptosis of neuroepithelial cells in all phases of the cell cycle or that apoptosis occurs independently of cell cycle arrest. Whereas a previous study showed that apoptosis of the human hepatoma HepG2 cells induced by folate deficiency was specific for S- and/or G2-phase arrest \[[@r13]\], the present result suggests that MTX induces apoptosis of neuroepithelial cells through a mechanism other than S- and/or G2-phase arrest.

In the present study, the pyknotic, TUNEL and cleaved caspase-3 indices of neuroepithelial cells in the telencephalon peaked 36 hr after treatment with MTX at GD 13 ([Table 5](#tbl_005){ref-type="table"}Table 5.Timing of the maximal level of cell death indices and minimal level of cell proliferation indices in the telencephalon after DNA-damaging chemicals treatmentMaximal level of cell death indicesMinimal level of cell proliferation indicesPyknosisTUNELCleaved caspase-3MitosisPhospho-histone H31-β-D-arabinofuranosylcytosine9 hr------------Ethylnitrosourea12 hr------------T-2 toxin---12 hr---------5-azacytide---12 hr---24 hr---Busulfan------48 hr---48 hr6-Mercaptopurine---------36 hr36 hrMethotrexate36 hr36 hr36 hr6--36 hr6--36 hr). The index of pyknotic cells in the telencephalon peaked 9--12 hr after treatment with Ara-C \[[@r43]\] and ENU \[[@r19]\]. The index of TUNEL-positive cells peaked 12 hr after treatment with T-2 toxin and 5AzC \[[@r34], [@r39]\], and the index of cleaved caspse-3-positive cells peaked 48 hr after treatment with busulfan \[[@r30]\]. On the other hand, in the present study, mitotic and phospho-histone H3 indices in telencephalon treated with MTX decreased significantly at 6 hr and maintained that low level throughout the experimental period ([Table 5](#tbl_005){ref-type="table"}). The mitotic cell index in the telencephalon significantly decreased at 30 hr and reached its lowest level 36 hr after treatment with 6-MP \[[@r17]\], while the mitotic cell index peaked 6 hr, decreased thereafter and reached the minimal level 24 hr after treatment with 5AzC \[[@r40]\]. The index of phospho-histone H3-positive cells significantly decreased at 24 hr and reached its minimal level 48 hr after treatment with busulfan \[[@r30]\], while it reached the lowest level 36 hr after treatment with 6-MP \[[@r18]\]. The distribution of pyknotic neuroepithelial cells and the time-course changes of the indices of pyknotic and mitotic neuroepithelial cells in the telencephalic wall were different from those of the previously-mentioned other DNA-damaging chemicals. These differences may reflect the disparity in mechanisms of apoptosis and the inhibition of cell proliferation in neuroepithelial cells among DNA-damaging chemicals. Further investigations should be conducted to clarify the true cause of these differences.

In the present study, MTX induced fewer pyknotic changes of neuroepithelial cells in the metencephalon than in other brain regions. The result of a previous study suggested that cell-proliferative activity was associated with the sensitivity to MTX \[[@r37]\]. The different pyknotic indices of the MTX-treated group among the brain regions in the present study may reflect the disparity of cell-proliferative activity. In a previous study \[[@r44]\], MTX inhibited the development of individual brain parts to varying degrees in chick embryos. The same study suggested that the different effects of MTX on various brain parts may be due to different schedules of cell proliferation among individual brain parts. Other previous studies demonstrated that busulfan or 5-Fu treatment at GD13 in rat fetus induced pyknotic changes of neuroepithelial cells in metencephalon to the same degree as those in diencephalon and mesencephalon \[[@r29], [@r42]\]. These results suggest that there are differences in sensitivities to MTX, busulfan and 5-Fu of neuroepithelial cells in the metencephalon.

There are several studies describing brain malformation induced by MTX in human and rabbits \[[@r2], [@r16], [@r35]\]. A report of Seidahmed *et al.* \[[@r35]\] described that 2.5 mg of MTX 3 times a day for 7 days, for a total of 52.5 mg at 6 weeks of gestation, induced alobar holoprosencephaly, cerebellar hypoplasia and agenesis of the corpus callosum in human. Corona-Rivera *et al.* \[[@r2]\] reported that MTX 5 mg/day treatment for 14 days at the 5th week post-conception induced brain anomalies including semilobar holoprosencephaly and hydrocephalus in human. In rabbits, MTX 19.2 mg/kg administration during GD 10--15 induced various anomalies including hydrocephalus \[[@r16]\]. In the present study, single dose-administration of MTX 30 mg/kg on GD 13 induced fetal death 48 hr after treatment, and the cause of fetal death in the present study may be relevant to dose, number and timing of MTX administration.

In conclusion, MTX administration of 30 mg/kg on GD 13 induced apoptosis of neuroepithial cells and inhibited mitosis of these cells in telencephalon 6--36 hr after treatment. The distribution of apoptotic neuroepithelial cells in the telencephalic wall and the whole brain and the time-course changes of the indices of apoptotic and mitotic neuroepithelial cells were different from other DNA-damaging chemicals reported previously. While the detailed mechanisms of MTX-induced neuroepithelial cell damage in fetal brain remain unclear, the present results provide fundamental information about the fetal brain damage induced by MTX. The present results serve to elucidate the pathogenesis of nervous system anomalies resulting from failed pregnancy termination with MTX or when mothers who are taking MTX for medical reasons become pregnant inadvertently. To our knowledge, this is the first report demonstrating histopathological findings of fetal brain damage induced by MTX.
